Cited by 1,149Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolismTrace Elements in Health

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., Marsden, C. D.·1989·Journal of Neurochemistry

DOI 10.1111/j.1471-4159.1989.tb07264.x

Open this paper in CoChat — free account

Abstract

Levels of iron, copper, zinc, manganese, and lead were measured by inductively coupled plasma spectroscopy in parkinsonian and age-matched control brain tissue. There was 31-35% increase in the total iron content of the parkinsonian substantia nigra when compared to control tissue. In contrast, in the globus pallidus total iron levels were decreased by 29% in Parkinson's disease. There was no change in the total iron levels in any other region of the parkinsonian brain. Total copper levels were reduced by 34-45% in the substantia nigra in Parkinson's disease; no difference was found in the other brain areas examined. Zinc levels were increased in substantia nigra in Parkinson's disease by 50-54%, and the zinc content of the caudate nucleus and lateral putamen was also raised by 18-35%. Levels of manganese and lead were unchanged in all areas of the parkinsonian brain studied when compared to control brains, except for a small decrease (20%) in manganese content of the medial putamen. Increased levels of total iron in the substantia nigra may cause the excessive formation of toxic oxygen radicals, leading to dopamine cell death.

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.1989.tb07264.x

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
The effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397
Self-citation
Chronic parkinsonism secondary to intravenous injection of meperidine analogues
Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H., Caine, E. D., Reichert, C. M., & Kopin, I. J. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90006-4 · Cited by 1,377
FERRITIN: STRUCTURE, GENE REGULATION, AND CELLULAR FUNCTION IN ANIMALS, PLANTS, AND MICROORGANISMS
Theil, E. C. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.001445 · Cited by 1,337
Increased nigral iron content in postmortem parkinsonian brain
Dexter, D. T., Wells, F. R., Agid, F., Agid, Y., Lees, A. J., Jenner, P., & Marsden, C. D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91361-4 · Cited by 963
Self-citation
Autoxidation versus Covalent Binding of Quinones as the Mechanism of Toxicity of Dopamine, 6-Hydroxydopamine, and Related Compounds toward C1300 Neuroblastoma Cells in Vitro
Graham, D. G., Tiffany, S. M., BELL, W. R., & Gutknecht, W. F. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13536-0 · Cited by 953
The importance of free radicals and catalytic metal ions in human diseases.
Halliwell, B., & Gutteridge, J. M. C. (1985) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(85)90001-9 · Cited by 941
Iron-Responsive Elements: Regulatory RNA Sequences That Control mRNA Levels and Translation
Casey, J. L., Hentze, M. W., Koeller, D. M., Caughman, S. W., Rouault, T. A., Klausner, R. D., & Harford, J. B. (1988) · Science · doi:10.1126/science.2452485 · Cited by 709
Brain Peroxidase and Catalase in Parkinson Disease
Ambani, L. M., Woert, M. H. V., & Murphy, S. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490440064010 · Cited by 404

Show all 29 references

Research works printed but not linked: 4

Barbeau A., 1985, Uneven prevalence of Parkinson's disease in the province of Quebec, Can. J. Neurol. Sci., 12, 169
Barbeau A., 1986, Advances in Neurology, 299
Donaldson J., 1974, Advances in Neurology, 245
Youdim M. B. H., 1985, Handbook of Neurochemisiry, 731

Sorted by citations

Items 501–600 of 1,000

Melatonin and 6‐hydroxymelatonin protect against iron‐induced neurotoxicity
Maharaj, D. S., Maharaj, H., Daya, S., & Glass, B. D. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03532.x · Cited by 51
Inhibition of catechol-O-methyltransferase (COMT) as well as tyrosine and tryptophan hydroxylase by the orally active iron chelator, 1,2-dimethyl-3-hydroxypyridin-4-one (L1, CP20), in rat brain in vivo
Waldmeier, P. C., Buchle, A.-M., & Steulet, A.-F. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90222-i · Cited by 51
Toxic Effects of Iron for Cultured Mesencephalic Dopaminergic Neurons Derived from Rat Embryonic Brains
Michel, P. P., Vyas, S., & Agid, Y. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08882.x · Cited by 51
Self-citation
Trace Elements in Alzheimer’s Disease and Dementia: The Current State of Knowledge
Tyczyńska, M., Gędek, M., Brachet, A., Stręk, W., Flieger, J., Teresiński, G., & Baj, J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082381 · Cited by 50
A coumarin-based fluorescent probe for monitoring labile ferrous iron in living systems
Long, L., Wang, N., Han, Y., Huang, M., Yuan, X., Cao, S., Gong, A., & Wang, K. (2018) · The Analyst · doi:10.1039/c8an00556g · Cited by 50
Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping
Shahmaei, V., Faeghi, F., Mohammadbeigi, A., Hashemi, H., & Ashrafi, F. (2019) · European Journal of Radiology Open · doi:10.1016/j.ejro.2019.04.005 · Cited by 50
Monoamine transporter inhibitors and norepinephrine reduce dopamine‐dependent iron toxicity in cells derived from the substantia nigra
Paris, I. B., Martinez-Alvarado, P., Perez-Pastene, C., Vieira, M. N. N., Olea‐Azar, C., Raisman‐Vozari, R., Cárdenas, S., Graumann, R. T., Caviedes, P. A., & Segura‐Aguilar, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02931.x · Cited by 50
Iron and neurodegeneration
Olanow, C. W., & Youdim, M. B. H. (1996) · Elsevier eBooks · doi:10.1016/b978-012525445-8/50006-0 · Cited by 50
Iron prochelator BSIH protects retinal pigment epithelial cells against cell death induced by hydrogen peroxide
Charkoudian, L. K., Dentchev, T., Lukinova, N., Wolkow, N., Dunaief, J. L., & Franz, K. J. (2008) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2008.08.001 · Cited by 49
Serum Levels of Trace Elements and Heavy Metals in Patients with Acute Hemorrhagic Stroke
Karadaş, S., Sayın, R., Aslan, M., Gönüllü, H., Katı, C., Dursun, R., Duran, L., Gönüllü, E., & Demir, H. (2013) · The Journal of Membrane Biology · doi:10.1007/s00232-013-9621-0 · Cited by 48
Newly Diagnosed Anemia Increases Risk of Parkinson’s disease: A Population-Based Cohort Study
Hong, C., Huang, Y. H., Liu, H. Y., Chiou, H., Chan, L., & Chien, L. (2016) · Scientific Reports · doi:10.1038/srep29651 · Cited by 50
Longitudinal changes of cortical microstructure in Parkinson's disease assessed with T1 relaxometry
Nürnberger, L., Gracien, R., Hok, P., Hof, S., Rüb, U., Steinmetz, H., Hilker, R., Klein, J. C., Deichmann, R., & Baudrexel, S. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.12.025 · Cited by 48
Rasagiline: an anti-Parkinson drug with neuroprotective activity
Youdim, M. B. H. (2003) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.3.6.737 · Cited by 49
GDNF and NT-4 Protect Midbrain Dopaminergic Neurons from Toxic Damage by Iron and Nitric Oxide
Lingor, P., Unsicker, K., & KRIEGLSTEIN, K. G. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7339 · Cited by 48
Quantitative evaluation of brain iron accumulation in different stages of Parkinson's disease
Li, K. R., Avecillas-Chasin, J. M., Nguyen, T. D., Gillen, K. M., Dimov, A., Chang, E., Skudin, C., Kopell, B. H., Wang, Y., & Shtilbans, A. (2021) · Journal of Neuroimaging · doi:10.1111/jon.12957 · Cited by 47
Synthesis, Characterization, Biomedical Application, Molecular Dynamic Simulation and Molecular Docking of Schiff Base Complex of Cu(II) Supported on Fe3O4/SiO2/APTS
Malekshah, R. E., Fahimirad, B., & Khaleghian, A. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s231062 · Cited by 47
Serum Uric Acid and the Risk of Dementia: A Systematic Review and Meta-Analysis
Zhou, Z., Zhong, S., Liang, Y., Zhang, X., Zhang, R., Kang, K., Qu, H., Xu, Y. H., Zhao, C., & Zhao, M. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.625690 · Cited by 46
Free radical scavenging properties of apomorphine enantiomers and dopamine: Possible implication in their mechanism of action in parkinsonism
Sam, E., & Verbeke, N. (1995) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02251227 · Cited by 47
Pulling back the mitochondria’s iron curtain
David, S. B. Z., Shkuri, L., & Ast, T. (2025) · npj Metabolic Health and Disease · doi:10.1038/s44324-024-00045-y · Cited by 59
The Role of Trace Metallic Elements in Neurodegenerative Disorders: Quantitative Analysis Using XRF and XANES Spectroscopy
Ide‐Ektessabi, A., & Rabionet, M. (2005) · Analytical Sciences · doi:10.2116/analsci.21.885 · Cited by 46
The Ferroxidase Hephaestin But Not Amyloid Precursor Protein is Required for Ferroportin-Supported Iron Efflux in Primary Hippocampal Neurons
Ji, C., Steimle, B. L., Bailey, D. K., & Kosman, D. J. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0568-z · Cited by 50
Correlation of Ferroptosis and Other Types of Cell Death in Neurodegenerative Diseases
Dang, X., Huan, X., Du, X., Chen, X., Bi, M., Yan, C., Jiao, Q., & Jiang, H. F. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00861-6 · Cited by 46
DNA induced folding/fibrillation of alpha-synuclein: new insights in Parkinson's disease
Hegde, M. L. (2009) · Frontiers in bioscience · doi:10.2741/3628 · Cited by 46
Late-onset lipid peroxidation and neuronal cell death following transient forebrain ischemia in rat brain
Kondo, Y., Asanuma, M., Nishibayashi, S., Iwata, E., & Ogawa, N. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00836-6 · Cited by 46
The role of iron in neurodegenerative disorders: insights and opportunities with synchrotron light
Collingwood, J. F., & Davidson, M. R. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00191 · Cited by 45
Metal chelator EGCG attenuates Fe( III )‐induced conformational transition of α‐synuclein and protects AS ‐ PC 12 cells against Fe( III )‐induced death
Zhao, J., Xu, L., Liang, Q., Sun, Q. Y., Chen, C., Zhang, Y., Ding, Y., & Zhou, P. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14142 · Cited by 49
Formation of DNA Adducts and Oxidative Base Damage by Copper Mediated Oxidation of Dopamine and 6-Hydroxydopamine
Lévay, G. I., Ye, Q., & Bodell, W. J. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6560 · Cited by 45
Oxidative events in neuronal and glial cell-enriched fractions of rat cerebral cortex
Café, C., Torri, C., Bertorelli, L., Tartara, F., Tancioni, F., Gaetani, P., y Baena, R. R., & Marzatico, F. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)00086-d · Cited by 45
Different effects of oxidative stress on activation of transcription factors in primary cultured rat neuronal and glial cells
Iwata, E., Asanuma, M., Nishibayashi, S., Kondo, Y., & Ogawa, N. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00190-3 · Cited by 45
Paraquat-Induced Free Radical Reaction in Mouse Brain Microsomes
Yang, W., & Sun, A. Y. (1998) · Neurochemical Research · doi:10.1023/a:1022497319548 · Cited by 45
Widespread Decreases in Cerebral Copper Are Common to Parkinson's Disease Dementia and Alzheimer's Disease Dementia
Scholefield, M., Church, S. J., Xu, J., Patassini, S., Roncaroli, F., Hooper, N. M., Unwin, R. D., & Cooper, G. J. S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.641222 · Cited by 44
Free Radicals and Antioxidants in Muscular and Neurological Diseases and Disorders
Reznick, A. Z., & Packer, L. (1993) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-9116-5_37 · Cited by 44
Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures
Di Monte, D. A., Schipper, H. M., Hetts, S., & Langston, J. W. (1995) · Glia · doi:10.1002/glia.440150213 · Cited by 43
Manganese efflux in Parkinsonism: Insights from newly characterized SLC30A10 mutations
DeWitt, M. R., Chen, P., & Aschner, M. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.058 · Cited by 43
Iron as a cause of Parkinson disease – a myth or a well established hypothesis?
Friedman, A., Gałązka-Friedman, J., & Koziorowski, D. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70817-x · Cited by 43
Structural Characterization of a High Affinity Mononuclear Site in the Copper(II)-α-Synuclein Complex
Bortolus, M., Bisaglia, M., Zoleo, A., Fittipaldi, M., Benfatto, M., Bubacco, L., & Maniero, A. L. (2010) · Journal of the American Chemical Society · doi:10.1021/ja103338n · Cited by 43
Living with the enemy: from protein-misfolding pathologies we know, to those we want to know
Emwas, A.-H. M., Alghrably, M., Dhahri, M., Sharfalddin, A. A., Alsiary, R., Jaremko, M., Faa, G., Campagna, M., Congiu, T., Piras, M., et al. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101391 · Cited by 43
Desferoxamine reverses neonatal iron-induced recognition memory impairment in rats
de Lima, M. N. M., Presti-Torres, J., Caldana, F., Grazziotin, M. M., Scalco, F. S., Guimarães, M. R., Bromberg, E., Franke, S. I. R., Henriques, J. A. P., & Schröder, N. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.002 · Cited by 43
Alpha‐synuclein and its role in metal binding: Relevance to Parkinson's disease
Wright, J. A., & Brown, D. R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21461 · Cited by 44
Time Course Changes in the Dopaminergic Nigrostriatal System Following Transection of the Medial Forebrain Bundle: Detection of Oxidatively Modified Proteins in Substantia Nigra
Venero, J. L., Revuelta, M., Cano, J., & Machado, A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68062458.x · Cited by 43
Serum uric acid levels in Parkinson's disease and related disorders
Sakuta, H., Suzuki, K., Miyamoto, T., Miyamoto, M., Numao, A., Fujita, H., Watanabe, Y., & Hirata, K. (2016) · Brain and Behavior · doi:10.1002/brb3.598 · Cited by 42
Exploring multifunctional antioxidants as potential agents for management of neurological disorders
Sindhu, R. K., Kaur, P., Kaur, P., Singh, H., Batiha, G. E., & Verma, I. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17667-0 · Cited by 44
Parkinson's disease: pathological mechanisms and actions of piribedil
Jenner, P. G. (1992) · Journal of Neurology · doi:10.1007/bf00819559 · Cited by 42
Self-citation
A rationale for monoamine oxidase inhibition as neuroprotective therapy for parkinson's disease
Olanow, C. W. (1993) · Movement Disorders · doi:10.1002/mds.870080503 · Cited by 42
Dose- and time-dependent α-synuclein aggregation induced by ferric iron in SK-N-SH cells
Li, W.-J., Jiang, H., Song, N., & Xie, J.-X. (2010) · Neuroscience Bulletin · doi:10.1007/s12264-010-1117-7 · Cited by 41
Brain Iron Deposition and Sequence Characteristics in Parkinsonism
Rossi, M. E., Ruottinen, H., Elovaara, I., Ryymin, P., Soimakallio, S., Eskola, H. J., & Dastidar, P. (2010) · Investigative Radiology · doi:10.1097/rli.0b013e3181ec9c96 · Cited by 41
Iron Accumulation Is Not Homogenous among Patients with Parkinson’s Disease
Dashtipour, K., Liu, M., Kani, C., Dalaie, P., Obenaus, A., Simmons, D. B., Gatto, N. M., & Zarifi, M. (2015) · Parkinson s Disease · doi:10.1155/2015/324843 · Cited by 41
Iron in Neurodegenerative Disorders of Protein Misfolding: A Case of Prion Disorders and Parkinson's Disease
Singh, N., Haldar, S., Tripathi, A. K., McElwee, M. K., Horback, K., & Beserra, A. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5874 · Cited by 41
Elemental fingerprint: Reassessment of a cerebrospinal fluid biomarker for Parkinson's disease
Maass, F., Michalke, B., Willkommen, D., Leha, A., Schulte, C., Tönges, L., Mollenhauer, B., Trenkwalder, C., Rückamp, D., Börger, M., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104677 · Cited by 42
The quality of life in Parkinson's disease
Kuopio, A., Marttila, R. J., Helenius, H. Y. M., Toivonen, M., & Rinne, U. K. (2000) · Movement Disorders · doi:10.1002/1531-8257(200003)15:2 · Cited by 321
The genotoxicity and cytotoxicity of dermally-administered cadmium: effects of dermal cadmium administration.
Fasanya-Odewumi, C., Latinwo, L. M., Ikediobi, C. O., Gilliard, L., Sponholtz, G., Nwoga, J., Stino, F. K. R., Hamilton, N. K., & Erdos, G. W. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm.1.6.1001 · Cited by 41
Deubiquitylase OTUD3 prevents Parkinson’s disease through stabilizing iron regulatory protein 2
Jia, F., Li, H., Jiao, Q., Li, C., Fu, L., Cui, C., Jiang, H. F., & Zhang, L. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04704-0 · Cited by 40
DNA damage induced by catechol derivatives
Miura, T., Muraoka, S., Fujimoto, Y., & Zhao, K. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00156-3 · Cited by 40
Paraquat-Induced Cell Death in PC12 Cells
Yang, W., & Sun, A. Y. (1998) · Neurochemical Research · doi:10.1023/a:1020750706762 · Cited by 40
Effects of tumor necrosis factor on receptor-mediated endocytosis and barrier functions of bovine brain capillary endothelial cell monolayers
Descamps, L., Cecchelli, R., & Torpier, G. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00226-3 · Cited by 39
Changes in some pro-and antioxidants in rat cerebellum after chronic alcohol intake
Rouach, H., Houzé, P., Gentil, M., Orfanelli, M.-T., & Nordmann, R. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00770-8 · Cited by 40
Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys
Faucheux, B. A., Herrero, M. T., Villares, J., Lévy, R., Javoy-Agid, F., Obeso, J. A., Hauw, J., Agid, Y., & Hirsch, É. C. (1995) · Brain Research · doi:10.1016/0006-8993(95)00629-5 · Cited by 41
Self-citation
Neurotoxicity and neuroprotection in Parkinson's disease
Lange, K. W., Youdim, M. B. H., & Riederer, P. F. (1992) · PubMed · doi:10.5283/epub.25435 · Cited by 40
Glutathione Depletion and Concomitant Elevation of Susceptibility in Patients with Parkinson’s Disease: State-of-the-Art MR Spectroscopy and Neuropsychological Study
Shukla, D., Goel, A., Mandal, P. K., Joon, S., Punjabi, K., Arora, Y., Kumar, R., Mehta, V. S., Singh, P., Maroon, J. C., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00717 · Cited by 39
Dopamine- and zinc-induced autophagosome formation facilitates PC12 cell survival
Hung, H., Huang, W., & Pan, C. (2013) · Cell Biology and Toxicology · doi:10.1007/s10565-013-9261-2 · Cited by 39
Dopamine D2/D3 Agonists with Potent Iron Chelation, Antioxidant and Neuroprotective Properties: Potential Implication in Symptomatic and Neuroprotective Treatment of Parkinson’s Disease
Gogoi, S., Antonio, T., Rajagopalan, S., Reith, M. E. A., Andersen, J. K., & Dutta, A. K. (2011) · ChemMedChem · doi:10.1002/cmdc.201100140 · Cited by 39
Neuromelanin in Parkinson’s Disease: from Fenton Reaction to Calcium Signaling
Knörle, R. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9804-z · Cited by 39
Au Nanostructured Surfaces for Electrochemical and Localized Surface Plasmon Resonance-Based Monitoring of α-Synuclein–Small Molecule Interactions
Cheng, X. R., Wallace, G. Q., Lagugné‐Labarthet, F., & Kerman, K. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/am507972b · Cited by 39
Cytosolic labile zinc accumulation in degenerating dopaminergic neurons of mouse brain after MPTP treatment
Lee, J., Son, H. J., Choi, J. H., Cho, E., Kim, J., Chung, S. J., Hwang, O., & Koh, J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.046 · Cited by 39
Intranigral injected iron progressively reduces striatal dopamine metabolism
Wesemann, W., Blaschke, S., Solbach, M., Grote, C., Clement, H. ‐., & Riederer, P. F. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260941 · Cited by 39
Blood donations, iron stores, and risk of Parkinson's disease
Logroscino, G., Chen, H., Wing, A., & Ascherio, A. (2006) · Movement Disorders · doi:10.1002/mds.20826 · Cited by 38
Iron chelation beyond transfusion iron overload
Pietrangelo, A. (2007) · American Journal of Hematology · doi:10.1002/ajh.21101 · Cited by 38
Ceruloplasmin and superoxide dismutase (SOD1) in Parkinson's disease: A follow-up study
Tórsdóttir, G., Sveinbjörnsdóttir, S., Kristinsson, J., Snædal, J., & Jøhannesson, T. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.10.015 · Cited by 38
Simultaneous Single-Cell Analysis of Na+, K+, Ca2+, and Mg2+in Neuron-Like PC-12 Cells in a Microfluidic System
Li, L., Fan, Y., Li, Q., Sheng, R., Si, H., Fang, J., Tong, L., & Tang, B. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b05045 · Cited by 38
Reproducing kernel particle method for two-dimensional time-space fractional diffusion equations in irregular domains
Lin, Z., Liu, F., Wang, D., & Gu, Y. (2018) · Engineering Analysis with Boundary Elements · doi:10.1016/j.enganabound.2018.10.002 · Cited by 38
Nicotine protects against manganese and iron-induced toxicity in SH-SY5Y cells: Implication for Parkinson's disease
Getachew, B., Csoka, A. B., Aschner, M., & Tizabi, Y. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.12.003 · Cited by 38
Inhibition of copper transporter 1 prevents α-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson's disease
Gou, D.-H., Huang, T., Li, W., Gao, X.-D., Haikal, C., Wang, X.-H., Song, D., Liang, X., Zhu, L., Tang, Y. C., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101795 · Cited by 40
Absence of Mutations in Superoxide Dismutase and Catalase Genes in Patients With Parkinson's Disease
Parboosingh, J. S., Rousseau, M., Rogan, F., Amit, Z., Chertkow, H. M., Johnson, W. G., Manganaro, F., Schipper, H., Curran, T. J., Stoessl, A. J., et al. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540360038013 · Cited by 38
The toxic metal hypothesis for neurological disorders
Pamphlett, R., & Bishop, D. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1173779 · Cited by 44
Scutellarin inhibits the uninduced and metal-induced aggregation of α-Synuclein and disaggregates preformed fibrils: implications for Parkinson's disease
Zaidi, F. K., & Deep, S. (2020) · Biochemical Journal · doi:10.1042/bcj20190705 · Cited by 37
Recent Updates in Redox Regulation and Free Radical Scavenging Effects by Herbal Products in Experimental Models of Parkinson’s Disease
Koppula, S., Kumar, H., More, S. V., Lim, H.-W., Hong, S.-M., & Choi, D. (2012) · Molecules · doi:10.3390/molecules171011391 · Cited by 38
Inflammation in parkinson’s disease
Hald, A., van Beek, J., & Lotharius, J. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5688-5_12 · Cited by 37
An immunohistochemical study on manganese superoxide dismutase in Parkinson's disease
Yoritaka, A., Hattori, N., Mori, H., Kato, K., & Mizuno, Y. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)05339-7 · Cited by 37
Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models
Capucciati, A., Zucca, F. A., Monzani, E., Zecca, L., Casella, L., & Hofer, T. (2021) · Antioxidants · doi:10.3390/antiox10060824 · Cited by 36
Baicalein Attenuates Brain Iron Accumulation through Protecting Aconitase 1 from Oxidative Stress in Rotenone-Induced Parkinson’s Disease in Rats
Liu, R., Zhang, S., Zhang, W., Zhao, X., & Du, G. (2022) · Antioxidants · doi:10.3390/antiox12010012 · Cited by 36
Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson’s Disease-Associated LRRK2 Gene Mutations
Loeffler, D. A., Klaver, A. C., Coffey, M. P., Aasly, J. O., & LeWitt, P. A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00089 · Cited by 36
Brain iron concentrations in the pathophysiology of children with attention deficit/hyperactivity disorder: a systematic review
Degremont, A., Jain, R., Philippou, E., & Latunde-Dada, G. O. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa065 · Cited by 36
Metal Imbalance in Neurodegenerative Diseases with a Specific Concern to the Brain of Multiple Sclerosis Patients
Dalès, J.-P., & Desplat‐Jégo, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239105 · Cited by 36
Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection
Kincses, Z. T., & Vécsei, L. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00150.x · Cited by 39
Transcriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson’s disease
Basu, S., Je, G., & Kim, Y. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.54 · Cited by 39
Challenges and complexities of α-synuclein toxicity: new postulates in unfolding the mystery associated with Parkinson’s disease
Hegde, M. L., & Rao, K. S. J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.015 · Cited by 37
What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson’s disease?
Youdim, M. B. H. (2003) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-0643-3_5 · Cited by 36
L-DOPA treatment from the viewpoint of neuroprotection
Ogawa, N., Asanuma, M., Miyazaki, I., Diaz-Corrales, F. J. J., & Miyoshi, K. (2005) · Journal of Neurology · doi:10.1007/s00415-005-4006-7 · Cited by 36
What Process Causes Nigral Cell Death in Parkinson’s Disease?
Jenner, P. G. (1992) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30217-2 · Cited by 36
Self-citation
Copper homeostasis and the ubiquitin proteasome system
Zhang, B., & Burke, R. (2023) · Metallomics · doi:10.1093/mtomcs/mfad010 · Cited by 36
Considerations for measuring iron in post-mortem tissue of Parkinson’s disease patients
Hare, D. J., Gerlach, M., & Riederer, P. F. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0898-4 · Cited by 35
Zinc rescues dopaminergic SK–N–SH cell lines from methamphetamine-induced toxicity
Ajjimaporn, A., Shaik, S., Ebadi, M., & Govitrapong, P. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.09.006 · Cited by 35
Estimation of the iron concentration in excised gray matter by means of proton relaxation measurements
Ye, F. Q., Martin, W. R. W., & Allen, P. S. (1996) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910350304 · Cited by 35
Preferential expression of superoxide dismutase messenger RNA in melanized neurons in human mesencephalon
Zhang, P., Damier, P., Hirsch, É. C., Agid, Y., Ceballos-Picot, I., Sinet, P., Nicole, A., Laurent, M., & Javoy-Agid, F. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90463-p · Cited by 35
Self-citation
Synergistic effects of dopamine and Zn2+ on the induction of PC12 cell death and dopamine depletion in the striatum: possible implication in the pathogenesis of Parkinson's disease
Lo, H.-S., Chiang, H., Lin, A. M.-Y., Chiang, H.-Y., Chu, Y., & Kao, L. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.05.003 · Cited by 34
The history of the research of iron in parkinsonian substantia nigra
Friedman, A., & Gałązka-Friedman, J. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0894-8 · Cited by 34
Midbrain dopaminergic neurons are protected from radical induced damage by GDF-5 application
Lingor, P., Unsicker, K., & KRIEGLSTEIN, K. G. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050146 · Cited by 34
Pathological evidence for oxidative stress in Parkinson's disease and related degenerative disorders
Jenner, P. G., & Olanow, C. W. (1996) · Elsevier eBooks · doi:10.1016/b978-012525445-8/50004-7 · Cited by 34
Self-citation
Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis
Ferrari, E., Engelen, M., Monzani, E., Sturini, M., Girotto, S., Bubacco, L., Zecca, L., & Casella, L. (2012) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-012-0951-7 · Cited by 34
Mitochondrial metals as a potential therapeutic target in neurodegeneration
Grubman, A., White, A. R., & Liddell, J. R. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12513 · Cited by 33

Authors: Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D.
Affiliations: King's College London (GB)
National Hospital for Neurology and Neurosurgery (GB)
Inserm (FR)
Corresponding author: Jenner, P.
ORCID: Dexter, D. T.
Jenner, P.
Venue: Journal of Neurochemistry
Publisher: Wiley
Published: 1989-06
Volume: 52
Issue: 6
Pages: 1830-1836
ISSN: 0022-3042 (ISSN-L)
1471-4159
DOI: 10.1111/j.1471-4159.1989.tb07264.x
OpenAlex: W1985613988
Cited by: 1,149
References: 29
Citations by year: 2026: 18 · 2025: 26 · 2024: 31 · 2023: 32 · 2022: 46 · 2021: 42 · 2020: 35 · 2019: 33 · 2018: 35 · 2017: 41 · 2016: 45 · 2015: 21 · 2014: 37 · 2013: 45 · 2012: 41
FWCI: 24.67
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 6335 d)
Locations: Journal of Neurochemistry (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
Keywords: Parkinson's disease, substantia nigra, iron, copper, zinc, manganese, lead, globus pallidus, caudate nucleus, putamen, oxidative stress, neurodegeneration
MeSH terms: Aged, Aged, 80 and over, Brain, Female, Humans, Ions, Iron, Male, Metals, Parkinson Disease, Substantia Nigra, Tissue Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks